Revance Therapeutic (RVNC) PT Lowered to $32 at Needham & Company

May 9, 2019 12:07 PM EDT Send to a Friend
Needham & Company analyst Serge ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login